Literature DB >> 11069504

The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis.

G Yosipovitch1, A Goon, J Wee, Y H Chan, C L Goh.   

Abstract

BACKGROUND: Many patients with psoriasis are known to suffer from itch. However, the data available regarding itch and its characteristics in psoriasis are sparse.
OBJECTIVES: To examine the prevalence of pruritus and various related clinical characteristics in 101 patients with extensive psoriasis.
METHODS: A structured questionnaire was used.
RESULTS: Generalized pruritus was a feature of psoriasis in 84% of the patients. In 77% of these it appeared on a daily basis. It involved all areas of the body, had prolonged duration and appeared mainly in the evening and at night. The pruritus significantly affected quality of life. Important daily factors that were found to exacerbate the itch were ambient heat (81%), skin dryness (80%), sweating (65%) and stress (55%). Important factors that were found to ameliorate itch were sleep (57%) and cold showers (55%). The pruritus was found to be unresponsive to most available antipruritics, including phototherapy. Itch intensity as reflected by a visual analogue scale did not correlate with Psoriasis Area and Severity Index scores; however, a highly significant correlation was obtained between the affective descriptors and itch intensity in the worst itch states (r = 0.6, P < 0.001).
CONCLUSIONS: Pruritus is a common feature of psoriasis and affects quality of life.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069504     DOI: 10.1046/j.1365-2133.2000.03829.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  75 in total

1.  Psoriasis in patients older than 65 years. A comparative study with younger adult psoriatic patients.

Authors:  R M Fernandez-Torres; S Paradela; E Fonseca
Journal:  J Nutr Health Aging       Date:  2012       Impact factor: 4.075

2.  [Pruritus and psoriasis : an important but frequently underestimated relation].

Authors:  E Weisshaar
Journal:  Hautarzt       Date:  2012-07       Impact factor: 0.751

3.  Cathelicidin LL-37 Induces Semaphorin 3A Expression in Human Epidermal Keratinocytes: Implications for Possible Application to Pruritus.

Authors:  Yoshie Umehara; Yayoi Kamata; Mitsutoshi Tominaga; François Niyonsaba; Hideoki Ogawa; Kenji Takamori
Journal:  J Invest Dermatol       Date:  2015-06-29       Impact factor: 8.551

4.  The antimicrobial peptide human beta-defensin 2 promotes itch through Toll-like receptor 4 signaling in mice.

Authors:  Jing Feng; Jialie Luo; Madison R Mack; Pu Yang; Feng Zhang; Guan Wang; Xuan Gong; Tao Cai; Zhinan Mei; Brian S Kim; Shijin Yin; Hongzhen Hu
Journal:  J Allergy Clin Immunol       Date:  2017-04-23       Impact factor: 10.793

Review 5.  Scalp Itch: A Systematic Review.

Authors:  Norma Elizabeth Vázquez-Herrera; Divya Sharma; Nouf Mohammed Aleid; Antonella Tosti
Journal:  Skin Appendage Disord       Date:  2017-11-29

6.  [Development of a German language questionnaire for assessing chronic pruritus (AGP-questionnaire): background and first results].

Authors:  E Weisshaar; S Ständer; U Gieler; U Matterne; U Darsow
Journal:  Hautarzt       Date:  2011-12       Impact factor: 0.751

Review 7.  Environmental risk factors and their role in the management of atopic dermatitis.

Authors:  Robert Kantor; Jonathan I Silverberg
Journal:  Expert Rev Clin Immunol       Date:  2016-07-28       Impact factor: 4.473

8.  Cognitive, behavioral, and physiological reactivity to chronic itching: analogies to chronic pain.

Authors:  Lisette Verhoeven; Floris Kraaimaat; Piet Duller; Peter van de Kerkhof; Andrea Evers
Journal:  Int J Behav Med       Date:  2006

9.  Psychosomatic factors in pruritus.

Authors:  Hong Liang Tey; Joanna Wallengren; Gil Yosipovitch
Journal:  Clin Dermatol       Date:  2013 Jan-Feb       Impact factor: 3.541

10.  The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groups.

Authors:  Denise Globe; Martha S Bayliss; David J Harrison
Journal:  Health Qual Life Outcomes       Date:  2009-07-06       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.